Current Month 2004
Article Features
  Standardizing the Teaching of Clinical Breast Exams
Celebrex Shows Promise for Reducing Tumor Mass in Breast Cancers
Study Finds Chemotherapy, But Not Tamoxifen, Associated with Stroke Risk After Breast Cancer Treatment
World's Largest Population Study on BRCA 1 and BRCA 2
BOADICEA Program Predicts Genetic Cancer Risk in Women
Study Finds HER2-positive Breast Cancer Invades Organs Due To Fatal Chemical Attraction
Eating Fruits and Vegetables Associated With Reduction in Cardiovascular Disease But Not Cancer
Potential New Oncogene May Be Missing Link in Cancer-Causing Chain
Multidisciplinary Life Sciences Project to Target Breast and Ovarian Cancers
New Radiotherapy Regimen Benefits Young Women with Breast Cancer
Barriers Preclude Rural Women from Breast Cancer Screening
Engineered Stem Cells Can Home In On Tumors


What To Advise To Patients At Risk of Hereditary Cancers

A new report says the rapid discovery of cancer-related genes and increasing awareness of genetic testing among patients makes it more important than ever for health professionals to learn how to identify and advise patients at risk for hereditary cancers. The report appears in CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society, and outlines the components of providing a hereditary cancer risk assessment.

Randa Sifri, MD, of Thomas Jefferson University in Philadelphia and colleagues say while hereditary cancers are relatively uncommon (estimated to account for 5 percent of diagnosed breast, ovarian, and colon cancers), they are important to recognize. They confer a high risk of multiple primary cancers that can occur at younger ages, affecting multiple family members who inherit a cancer-related gene.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon